MRI response categories predict organ preservation, local regrowth, and survival in rectal cancer patients post-neoadjuvant therapy. Restricted diffusion and abnormal nodal features on MRI indicate ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors A clinical and magnetic resonance imaging ...
Please provide your email address to receive an email when new articles are posted on . MRI can help determine which individuals with rectal cancer may not need surgery following neoadjuvant therapy.
This retrospective multicenter study analyzed 384 pCR patients (2010-2019) to assess pretreatment MRI markers' prognostic value. Disease-free survival (DFS) and overall survival (OS) were estimated ...
Colorectal cancer (CRC) is one of the most common and deadly forms of cancer worldwide. A key reason for its high death toll is that it often goes undetected until it reaches an advanced stage.
Findings can save some lower-risk patients surgery after chemo, radiation. (HealthDay News) — Restaging magnetic resonance imaging (MRI) can predict organ preservation and survival with rectal cancer, ...
A worrying study suggests one form of bowel cancer is becoming increasingly common in young people. While cases in older adults have fallen thanks to screening and awareness, diagnoses in younger ...